PLS3 is one of the earliest SS biomarker genes identified and is consistently upregulated in the majority of SS cases [15,97,98], including SS without erythroderma [99], but is absent in the blood of normal donors, BID, and MF patients without blood involvement [10,97,98,100]. Here, PLS3 is linked to synovial sarcoma.